Fundraising Fox

Nicholas Haft

Investor

Managing Director at OMX Ventures

New York, New York

Writes $500K – $15M checks · typically $7.8M

About

Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.

LinkedIn ↗X / Twitter ↗

Invests in

Biotech

Experience

  1. OMX VenturesManaging Directorcurrent2020 — presentNew York, New York, United States
  2. Delix TherapeuticsCo-Foundercurrent2019 — presentNew York, United States
  3. Arcos VenturesManaging Director2014 — 2020New York, United States

Education

  1. The Wharton School2007 — 2011

Same school

Also attended The Wharton School1,366

Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures

+ 1,360 more

Investments

Investor

10X GenomicsCompass PathwaysFinch TherapeuticsGinkgo BioworksImagenPendulum Therapeutics

Per the firm's website.

Colleagues at OMX Ventures

Craig Asher
Managing Director at OMX Ventures
Daniel Fero
Managing Director at OMX Ventures
Fred Sweeney
Venture Partner at OMX Ventures
John Nawrocki
Chief Financial Officer at OMX Ventures
Natasha Azar
Vice President Investor Relations at OMX Ventures
Paul Conley
Venture Partner at Vertical Venture Partners
Swetha Murali
Vice President at OMX Ventures
Tim Richardson
Venture Partner at OMX Ventures

Network1

Daniel Fero
Managing Director at OMX Ventures

Investors connected to Nicholas in public investor directories — a warm-intro map.